康宁杰瑞制药-B 港股通 空最新回购 (2026-06-04) 官网 ( 09966.hk) | -61.18 | 4.07 | 0% | 上市时间2019-12-12股价7.96港币涨跌幅4.60%成交金额739.93万港币换手率0.10%市值77.56亿港币H股市值77.56亿港币总股本9.74亿H股本9.74亿每手股数1,000上市至今年化投资收益率-7.78%港股通持仓占H股比例17.18% (12.69亿港币2026-07-22) 累计做空占H股比例1.71% (1.16亿港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 备注 (3): | 双击编辑备注 |
康宁杰瑞制药-B(09966) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 郭子建 | Independent Non Executive Director | 2021-08-27 | -- | |
| 2 | 蔚成 | Independent Non Executive Director - A/F | 2019-11-24 | -- | |
| 3 | 吳冬 | Independent Non Executive Director | 2019-11-24 | -- | |
| 4 | 蔣華良 | Independent Non Executive Director | 2019-11-24 | 2021-08-27 | |
| 5 | 劉陽 | Executive Director | 2019-07-03 | -- | |
| 6 | 徐霆 | Executive Director | Chairman, CEO | 2019-07-03 | -- |
| 7 | 許湛 | Non Executive Director | 2019-07-03 | 2023-06-30 | |
| 8 | 裘育敏 | Non Executive Director | 2019-07-03 | 2022-06-16 |